Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Regulated Industries committee approves substitute to expand Georgia medical cannabis program
Summary
The Regulated Industries committee approved a House substitute to Senate Bill 220 to expand delivery methods and qualifying conditions for Georgia's medical cannabis program, tighten physician accessibility rules and reduce maximum possession limits; committee rejected an amendment to remove a public‑use restriction and approved the substitute by voice vote.
The Regulated Industries committee approved a substitute to Senate Bill 220 on a voice vote after a daylong discussion that touched on dosage measurement, patient access, provider oversight and public‑use limits.
Dr. Newton, who presented the substitute developed by the Speaker's Blue Ribbon Study Committee, told members the bill replaces the label "low THC oil" with the more medically precise "medical cannabis," allows additional delivery methods beyond oil (including regulated vaporization), and shifts dosing from percentage measures to milligrams to improve clinical precision. "What we're looking at is how many milligrams are being delivered to the patient," Dr. Newton said, arguing milligrams are a clearer way for physicians to recommend and monitor dosing.
The substitute would lower the total amount a registered patient may possess compared with current law: instead of the roughly 28,000 milligram maximum allowed previously, the bill sets per‑package limits of up to 1,200 milligrams and a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
